Accuray Revenue 2006-2018 | ARAY
Accuray revenue from 2006 to 2018. Revenue can be defined as the amount of money a company receives from its customers in exchange for the sales of goods or services. Revenue is the top line item on an income statement from which all costs and expenses are subtracted to arrive at net income.
| Accuray Annual Revenue (Millions of US $) |
|
|---|---|
| 2018 | $405 |
| 2017 | $383 |
| 2016 | $399 |
| 2015 | $380 |
| 2014 | $369 |
| 2013 | $316 |
| 2012 | $409 |
| 2011 | $222 |
| 2010 | $222 |
| 2009 | $234 |
| 2008 | $210 |
| 2007 | $140 |
| 2006 | $53 |
| 2005 | $22 |
| Accuray Quarterly Revenue (Millions of US $) |
|
|---|---|
| Q2 2018 | $102 |
| Q1 2018 | $96 |
| Q4 2018 | $114 |
| Q3 2018 | $100 |
| Q2 2017 | $100 |
| Q1 2017 | $91 |
| Q4 2017 | $112 |
| Q3 2017 | $97 |
| Q2 2016 | $88 |
| Q1 2016 | $87 |
| Q4 2016 | $95 |
| Q3 2016 | $105 |
| Q2 2015 | $109 |
| Q1 2015 | $90 |
| Q4 2015 | $102 |
| Q3 2015 | $98 |
| Q2 2014 | $98 |
| Q1 2014 | $82 |
| Q4 2014 | $102 |
| Q3 2014 | $97 |
| Q2 2013 | $94 |
| Q1 2013 | $77 |
| Q4 2013 | $85 |
| Q3 2013 | $71 |
| Q2 2012 | $78 |
| Q1 2012 | $83 |
| Q4 2012 | $101 |
| Q3 2012 | $102 |
| Q2 2011 | $106 |
| Q1 2011 | $100 |
| Q4 2011 | $75 |
| Q3 2011 | $55 |
| Q2 2010 | $54 |
| Q1 2010 | $38 |
| Q4 2010 | $62 |
| Q3 2010 | $52 |
| Q2 2009 | $57 |
| Q1 2009 | $51 |
| Q4 2009 | $59 |
| Q3 2009 | $61 |
| Q2 2008 | $58 |
| Q1 2008 | $56 |
| Q4 2008 | $51 |
| Q3 2008 | $59 |
| Q2 2007 | $52 |
| Q1 2007 | $49 |
| Q4 2007 | $44 |
| Q3 2007 | $37 |
| Q2 2006 | $26 |
| Q1 2006 | $33 |
| Q3 2006 | $16 |
| Q2 2005 | $11 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Instruments Manufacturing | $0.448B | $0.405B |
| ACCURAY INCORPORATED based in Sunnyvale, Calif., is a global leader in the field of radiosurgery dedicated to providing an improved quality of life and a non-surgical treatment option for those diagnosed with cancer. Accuray develops and markets the CyberKnife Robotic Radiosurgery System, which extends the benefits of radiosurgery to include extracranial tumors, including those in the spine, lung, prostate, liver and pancreas. To date, the CyberKnife System has been used to treat more than 40,000 patients worldwide and currently more than 130 systems have been installed in leading hospitals in the Americas, Europe and Asia. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Thermo Fisher Scientific (TMO) | United States | $100.978B | 22.56 |
| Intuitive Surgical (ISRG) | United States | $62.759B | 59.07 |
| Edwards Lifesciences (EW) | United States | $36.781B | 37.67 |
| Fresenius Medical Care AG KGaA (FMS) | Germany | $23.554B | 15.93 |
| IDEXX Laboratories (IDXX) | United States | $18.175B | 49.49 |
| ABIOMED (ABMD) | United States | $16.202B | 106.96 |
| Hologic (HOLX) | United States | $13.485B | 20.39 |
| DexCom (DXCM) | United States | $13.140B | 0.00 |
| Teleflex (TFX) | United States | $12.967B | 29.44 |
| Varian Medical Systems (VAR) | United States | $11.956B | 29.87 |
| STERIS (STE) | United Kingdom | $10.363B | 26.63 |
| Masimo (MASI) | United States | $6.866B | 44.52 |
| Penumbra (PEN) | United States | $5.218B | 315.06 |
| LivaNova (LIVN) | United Kingdom | $4.825B | 30.97 |
| Globus Medical (GMED) | United States | $4.690B | 29.40 |
| Integra LifeSciences Holdings (IART) | United States | $4.359B | 21.23 |
| Wright Medical Group (WMGI) | Netherlands | $3.944B | 0.00 |
| Cantel Medical (CMD) | United States | $3.543B | 34.94 |
| Inogen (INGN) | United States | $2.977B | 64.26 |
| Tandem Diabetes Care (TNDM) | United States | $2.881B | 0.00 |
| Integer Holdings (ITGR) | United States | $2.678B | 22.42 |
| Glaukos (GKOS) | United States | $2.441B | 0.00 |
| AVANOS MEDICAL, INC (AVNS) | United States | $2.342B | 21.11 |
| OPKO Health (OPK) | United States | $1.653B | 0.00 |
| Nevro (NVRO) | United States | $1.426B | 0.00 |
| Tactile Systems Technology (TCMD) | United States | $1.369B | 217.97 |
| ORTHOFIX MEDICAL INC (OFIX) | United States | $1.239B | 35.78 |
| Luminex (LMNX) | United States | $1.155B | 52.86 |
| Pacific Biosciences Of California (PACB) | United States | $1.074B | 0.00 |
| CryoLife (CRY) | United States | $1.066B | 115.36 |
| Accelerate Diagnostics (AXDX) | United States | $1.055B | 0.00 |
| Intersect ENT (XENT) | United States | $1.047B | 0.00 |
| Natus Medical (BABY) | United States | $0.931B | 19.42 |
| Mesa Laboratories (MLAB) | United States | $0.901B | 36.84 |
| AngioDynamics (ANGO) | United States | $0.866B | 28.08 |
| ViewRay (VRAY) | United States | $0.786B | 0.00 |
| Veracyte (VCYT) | United States | $0.752B | 0.00 |
| AxoGen (AXGN) | United States | $0.676B | 0.00 |
| Quotient (QTNT) | Switzerland | $0.639B | 0.00 |
| TransEnterix (TRXC) | United States | $0.596B | 0.00 |
| OrthoPediatrics (KIDS) | United States | $0.481B | 0.00 |
| Si-Bone (SIBN) | United States | $0.460B | 0.00 |
| Oxford Immunotec Global (OXFD) | United Kingdom | $0.442B | 0.00 |
| Fluidigm (FLDM) | United States | $0.402B | 0.00 |
| GenMark Diagnostics (GNMK) | United States | $0.350B | 0.00 |
| Pulse Biosciences (PLSE) | United States | $0.338B | 0.00 |
| SeaSpine Holdings (SPNE) | United States | $0.313B | 0.00 |
| Neuronetics (STIM) | United States | $0.303B | 0.00 |
| Sientra (SIEN) | United States | $0.295B | 0.00 |
| RTI Surgical (RTIX) | United States | $0.291B | 46.80 |
| IRadimed (IRMD) | United States | $0.284B | 60.35 |
| Corindus Vascular Robotics (CVRS) | United States | $0.253B | 0.00 |
| Nuvectra (NVTR) | United States | $0.251B | 0.00 |
| CRH Medical (CRHM) | Canada | $0.239B | 41.63 |
| Helius Medical Technologies (HSDT) | United States | $0.177B | 0.00 |
| T2 Biosystems (TTOO) | United States | $0.165B | 0.00 |
| Ekso Bionics Holdings (EKSO) | United States | $0.135B | 0.00 |
| Sensus Healthcare (SRTS) | United States | $0.119B | 0.00 |
| Titan Medical (TMDI) | Canada | $0.098B | 0.00 |
| Ra Medical Systems (RMED) | United States | $0.093B | 0.00 |
| ConforMIS (CFMS) | United States | $0.085B | 0.00 |
| Biosig Technologies (BSGM) | United States | $0.085B | 0.00 |
| EDAP TMS (EDAP) | France | $0.079B | 0.00 |
| Apollo Endosurgery (APEN) | United States | $0.074B | 0.00 |
| HTG Molecular Diagnostics (HTGM) | United States | $0.072B | 0.00 |
| Alphatec Holdings (ATEC) | United States | $0.061B | 0.00 |
| Vermillion (VRML) | United States | $0.060B | 0.00 |
| Second Sight Medical Products (EYES) | United States | $0.057B | 0.00 |
| OBALON THERPTCS (OBLN) | United States | $0.048B | 0.00 |
| Electromed (ELMD) | United States | $0.048B | 24.74 |
| Xtant Medical Holdings (XTNT) | United States | $0.044B | 0.00 |
| Microbot Medical (MBOT) | United States | $0.039B | 0.00 |
| Viveve Medical (VIVE) | United States | $0.034B | 0.00 |
| Restoration Robotics (HAIR) | United States | $0.032B | 0.00 |
| Navidea Biopharmaceuticals (NAVB) | United States | $0.030B | 0.00 |
| PAVmed (PAVM) | United States | $0.027B | 0.00 |
| Lianluo Smart (LLIT) | China | $0.024B | 0.00 |
| DarioHealth (DRIO) | Israel | $0.024B | 0.00 |
| ReWalk Robotics (RWLK) | Israel | $0.023B | 0.00 |
| Neovasc (NVCN) | Canada | $0.019B | 0.00 |
| Dynatronics (DYNT) | United States | $0.018B | 0.00 |
| American Shared Hospital Services (AMS) | United States | $0.015B | 11.09 |
| Bioanalytical Systems (BASI) | United States | $0.015B | 47.00 |
| Nanovibronix (NAOV) | United States | $0.013B | 0.00 |
| ENDRA Life Sciences (NDRA) | United States | $0.012B | 0.00 |
| Avinger (AVGR) | United States | $0.011B | 0.00 |
| Presbia (LENS) | Ireland | $0.009B | 0.00 |
| Cesca Therapeutics (KOOL) | United States | $0.008B | 0.00 |
| Atossa Genetics (ATOS) | United States | $0.008B | 0.00 |
| InspireMD (NSPR) | Israel | $0.008B | 0.00 |
| Allied Healthcare Products (AHPI) | United States | $0.008B | 0.00 |
| Micron Solutions (MICR) | United States | $0.007B | 0.00 |
| Sunshine Heart Inc (CHFS) | United States | $0.006B | 0.00 |
| SINTX TECHNOLOGIES, INC (SINT) | United States | $0.006B | 0.00 |
| Check-Cap (CHEK) | Israel | $0.000B | 0.00 |
